The older bush stood aloof from the neocons, the warhawks, especially in the mideast and was hated for that. The younger bush was beloved by the neocons because he did just what they told him. The older brought on a period of solid economic growth. The younger bush cut taxes without reason and ushered in a financial disaster. Could we be watching an even better, fiercer rivalry between president s today . Its not personal this time, just historical. If barack obama turns into a big success, as discussed earlier tonight, can he outpace bill clinton in the history books . Can he be truly transformational, the word he used in saying what bill clinton was not. And that is the question. And dont think the two of those guys, clinton and obama, arent keeping a close watch on the scoreboard. And thats hardball for now. Thanks for being with us. The ed show with ed schultz starts right now. Good evening, americans, and welcome to the ed show from new york. The republicans president s day sale o
Wilkerson on the blind republican rage over benghazi. The luv gov is hitting the trail again. Im a bottom line kind of guy. Its going to hurt. Well show you his questionable ad. Plus, marco rubio disagrees with his own immigration plan because the president likes it. Mississippi finally got around to banning slavery this month. And the oscarnominated movie Silver Linings playbook is shining new light on treating Mental Illness. Director david o. Russell joins me tonight for the conversation. Good to have you with us tonight, folks. Thanks for watching. Its been exactly four years since an Economic Disaster was averted. Government spending undoubtedly was the key, the stimulus package. The president of the United States signed the american recovery and reinvestment act four years ago this week. It is responsible for saving and creating 2. 5 million jobs in this country at a time when the country was on the verge of a depression. But the stimulus did more than keep the country out of a h
Tonight the facts versus republican fantasy on the economy and the sequester. We have had a massive coverup on the part but a massive coverup of what . John mccain is at it again. Do you care whether four americans died . Retired colonel Lawrence Wilkerson on the blind republican rage over benghazi. The luv gov is hitting the trail again. Im a bottom line kind of guy. Its going to hurt. Well show you his questionable ad. Plus, marco rubio disagrees with his own immigration plan because the president likes it. Mississippi finally got around to banning slavery this month. And the oscarnominated movie Silver Linings playbook is shining new light on treating Mental Illness. Director david o. Russell joins me tonight for the conversation. Good to have you with us tonight, folks. Thanks for watching. Its been exactly four years since an Economic Disaster was averted. Government spending undoubtedly was the key, the stimulus package. The president of the United States signed the american reco
New York, NY (PRWEB) November 16, 2022 The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Diego for
Locanabio Announces Upcoming Preclinical Data Presentations at American Society of Gene and Cell Therapy Annual Meeting
News provided by
Share this article
Share this article
SAN DIEGO, May 5, 2021 /PRNewswire/ Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, today announced that new data from its preclinical research will be highlighted in oral and poster presentations at the 24th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting, taking place virtually from May 11-14, 2021. The presentations include results from a preclinical
in vivo study showing a novel PUF RNA-binding protein system delivered via an adeno-associated virus serotype 9 (AAV9) vector is safe and effective in eliminating toxic CUG repeats in a mouse model of myotonic dystrophy type 1 (DM1). Data also provide insights on the potential of a unique CRISPR/Cas13d gene